10-21670669-G-T
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001195626.3(MLLT10):c.1016G>T(p.Gly339Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000737 in 1,613,962 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001195626.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MLLT10 | NM_001195626.3 | c.1016G>T | p.Gly339Val | missense_variant | Exon 10 of 23 | ENST00000307729.12 | NP_001182555.1 | |
MLLT10 | NM_004641.4 | c.1016G>T | p.Gly339Val | missense_variant | Exon 10 of 24 | NP_004632.1 | ||
MLLT10 | NM_001324297.2 | c.281G>T | p.Gly94Val | missense_variant | Exon 12 of 25 | NP_001311226.1 | ||
MLLT10 | NR_136736.2 | n.1483G>T | non_coding_transcript_exon_variant | Exon 11 of 26 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152168Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000279 AC: 7AN: 250892 AF XY: 0.0000295 show subpopulations
GnomAD4 exome AF: 0.0000725 AC: 106AN: 1461794Hom.: 0 Cov.: 30 AF XY: 0.0000743 AC XY: 54AN XY: 727184 show subpopulations
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152168Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74336 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1016G>T (p.G339V) alteration is located in exon 9 (coding exon 9) of the MLLT10 gene. This alteration results from a G to T substitution at nucleotide position 1016, causing the glycine (G) at amino acid position 339 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at